NCT00398450View on ClinicalTrials.gov

Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

recombinant interferon alfa-2b

DRUG

azacitidine

Trial Locations (1)

92093-0658

Rebecca and John Moores UCSD Cancer Center, La Jolla

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Diego

OTHER

NCT00398450 - Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter